Lacosamide: An adjunctive agent for partial-onset seizures and potential therapy for neuropathic pain

Annals of Pharmacotherapy

Volumn 43, Issue 11, 2009, Pages 1809-1817

  Harris, Jacklyn A ^a   Murphy, Julie A ^a  

^a ST LOUIS COLLEGE OF PHARMACY   (United States)

Author keywords

Lacosamide; Neuropathic pain; Partial onset seizures

Indexed keywords

ANTICONVULSIVE AGENT; HARKOSERIDE; PLACEBO;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTHRALGIA; ATAXIA; BACKACHE; BLURRED VISION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONVULSION; COORDINATION DISORDER; DAILY LIFE ACTIVITY; DEPRESSION; DIABETIC NEUROPATHY; DIPLOPIA; DIZZINESS; DRUG BIOAVAILABILITY; DRUG COST; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPILEPSY; FATIGUE; FOCAL EPILEPSY; FOOD AND DRUG ADMINISTRATION; HEADACHE; HEART DISEASE; HEPATITIS; HUMAN; INJECTION SITE PAIN; LIVER DISEASE; MAXIMUM TOLERATED DOSE; MEDLINE; META ANALYSIS; MYOCARDITIS; NAUSEA; NEPHRITIS; NEUROPATHIC PAIN; NYSTAGMUS; OPEN STUDY; PAIN ASSESSMENT; PRIORITY JOURNAL; PROTEIN BINDING; PUBLICATION; QUALITY OF LIFE; RASH; REVIEW; RHINOPHARYNGITIS; SIDE EFFECT; SINUSITIS; SLEEP; SOMNOLENCE; ST SEGMENT; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SYSTEMATIC REVIEW; T WAVE; TREATMENT CONTRAINDICATION; TREATMENT RESPONSE; TREMOR; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION; VERTIGO; VOMITING;

ACETAMIDES; ANALGESICS; ANTICONVULSANTS; CHEMOTHERAPY, ADJUVANT; DIABETIC NEUROPATHIES; EPILEPSIES, PARTIAL; HUMANS; MULTICENTER STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEIZURES;

EID: 70449730891     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M303     Document Type: Review

References (29)

1. Chang BS, Lowenstein DH. Epilepsy. N Engl J Med 2003;349:1257-1266
2. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-319
3. Garnett WR. Antiepileptic drug treatment: outcomes and adherence. Pharmacotherapy 2000;20:191S-9S.
4. Errington AC, Stohr T, Heers C, Lees G. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol Pharmacol 2008;73:157-169 (Pubitemid 350294207)
5. Beyreuther BK, Freitag J, Heers C, Krebsfanger N, Scharfenecker U, Stohr T. Lacosamide: a review of preclinical properties. CNS Drug Rev 2007;13:21-42.
6. Beydoun A, D'Souza J, Hebert D, Doty P. Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures. Expert Rev Neurother 2009;9:33-42.
7. Bailer M, Johannessen SI, Kupferberg HJ, Levy RH, Perucca E, Tomson T. Progress report on new antiepileptic drugs: a summary of the Eighth Eilat Conference (EILAT VIII). Epilepsy Res 2007;73:1-52. (Pubitemid 46091734)
8. Kehne JH, Kane JM, Chaney SF, et al. Preclinical characterization of MDL 27,192 as a potential broad spectrum anticonvulsant agent with neuroprotective properties. Epilepsy Res 1997;27:41-54.
9. Fountain NB, French JA, Privitera MD. Harkoseride: safety and tolerability of a new antiepileptic drug (AED) in patients with refractory partial seizures (abstract). Epilepsia 2000;41(suppl 7):169-170
10. Sachdeo R, Montouris G, Beydoun A, et al. An open-label, maximum tolerated dose trial to evaluate oral SPM 927 as adjunctive therapy in patients with partial seizures (abstract). Neurology 2003;60(suppl 1):A433.
11. Chung SS, Sperling M, Biton V, Krauss G, Beaman M, Hebert D. Lacosamide: efficacy and safety as oral adjunctive treatment for partial-onset seizures (abstract). Epilepsia 2007;48(S6):321.
12. Ben-Menachem E, Biton V, Jatuzis D, Abou-Khalil B, Doty P, Rudd GD. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia 2007;48:1308-1317 (Pubitemid 47063096)
13. Halasz P, Kalviainen R, Mazurkiewicz-Beldzinska M, et al. Adjunctive lacosamide for partial-onset seizures: efficacy and safety results from a randomized controlled trial. Epilepsia 2009;50:443-453
14. Krauss G, Ben-Menachem E, Mameniskiene R, Vaiciene N, Brock M, Whitesides J. Intravenous lacosamide (SPM 927) as replacement for oral lacosamide in subjects with partial seizures: a multicenter, open-label, inpatient safety and tolerability trial (abstract). Epilepsia 2006;47(suppl 4):163.
15. Biton V, Rosenfeld WE, Whitesides J, Fountain NB, Vaiciene N, Rudd GD. Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures. Epilepsia 2008;49:418-424 (Pubitemid 351294527)
16. Shaibani A, Biton V, Rauck R, Koch B, Simpson J. Long-term oral lacosamide in painful diabetic neuropathy: a two-year open-label extension trial. Eur J Pain 2009;13:458-463
17. Rauck RL, Shaibani A, Biton V, Simpson J, Koch B. Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebocontrolled study. Clin J Pain 2007;23:150-158 (Pubitemid 46150939)
18. McCleane G, Koch B, Rauschkolb C. A report of continuing analgesia after 12 months treatment with SPM 927 in six subjects with neuropathic pain. J Neuropathic Pain Symptom Palliation 2005;1:25-28
19. Bretschneider M, Bongardt S, Koch B. A multi-center, open-label, follow-on trial to assess the long-term safety and efficacy of lacosamide in subjects with painful diabetic neuropathy (abstract). J Pain 2006;7:S43.
20. Hidvegi T, Bretschneider M, Thierfelder S, Sommerville K, Bongardt S. Long-term efficacy of lacosamide in subjects with painful distal diabetic neuropathy (abstract). J Pain 2008;9:P27.
21. McCleane G, Koch B, Rauschkolb C. Does SPM 927 have an analgesic effect in human neuropathic pain? An open label study. Neurosci Lett 2003;352:117-120 (Pubitemid 37415139)
22. Graf R, Frye W, Simpson J. Lacosamide in long-term treatment of painful diabetic neuropathy (DNP) (abstract). Eur J Neurol 2007;14(suppl 1):260.
23. Bongardt S, Shaibani A, Kenney P, Simpson J. Lacosamide in painful distal diabetic neuropathy: results of a multi-center, placebo-controlled US trial (abstract). Eur J Neurol 2007;14(suppl 1):250.
24. Wymer JM, Garrison C, Simpson J, Koch B. A multicenter, randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of lacosamide in painful distal diabetic neuropathy (abstract). Ann Neurol 2006;60(suppl 3):S68.
25. Biton V. Lacosamide for the treatment of diabetic neuropathic pain. Expert Rev Neurother 2008;8:1649-1660
26. Vorchheimer DA. What is QT prolongation? J Fam Pract 2005 Jun;Suppl S4-7.
27. Package insert. Vimpat (lacosamide tablets and injection) Smyrna, GA: UCB, Inc., October 2008.
28. Lacosamide for epilepsy. Med Lett Drugs Ther 2009;51:50-52
29. Cardinal Health. www.cardinal.com (accessed 2009 May 22).